M. Stamatelou

发表

Multiple myeloma as the first manifestation of acquired immunodeficiency syndrome: a case report and review of the literature

D. Rontogianni, A. Pouli, H. Lemessiou, 2001, Annals of Hematology.

Serum transforming growth factor-beta 1 is related to the degree of immunoparesis in patients with multiple myeloma.

M. Kyrtsonis, A. Mouzaki, A. Maniatis, 1998, Medical oncology.

Liposome-Mediated Delivery of Radionuclides to Tumor Models for Cancer Radiotherapy: A Quantitative Analysis

Kostas Kostarelos, D. Emfietzoglou, M. Stamatelou, 1999 .

Soluble interleukin‐6 receptor (sIL‐6R), a new prognostic factor in multiple myeloma

C. Baxevanis, A. Maniatis, C. Zervas, 1996, British journal of haematology.

Evaluation of argyrophilic nucleolar organiser regions (AgNORs) in multiple myeloma

D. Daskalopoulou, S. Markidou, S. I. Papadhimitriou, 2000, Journal of clinical pathology.

Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single apheresis (SA) for rescuing patients after high-dose chemotherapy (HD.CHE) in various malignancies.

G. Koumakis, M. Vassilomanolakis, A. Efremidis, 1996, Bone marrow transplantation.

Chemotherapy-related acute rhabdomyolysis.

M. Mouratidou, M. Kotsopoulou, A. Pouli, 1992, Journal of the National Cancer Institute.

Recurrence of acute leukemia in donor cells after bone marrow transplantation: documentation by in situ DNA hybridization.

H. Prentice, A. Hoffbrand, M. Mouratidou, 1993, Bone marrow transplantation.

Spontaneous rupture of the spleen in a patient with amyloidosis associated with multiple myeloma

N. Apostolikas, M. Kotsopoulou, A. Pouli, 1995 .

An unusual cytogenetic abnormality involving chromosomes 1 and 7 in a case of chronic myelomonocytic leukemia.

C. Pangalos, C. Papaconstantinou, D. Abazis, 1995, Cancer genetics and cytogenetics.